With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies ...
It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...
VectorBuilder made an agreement with MaxCyte, a biotechnology and electroporation company. The partnership will focus on ...
The launch puts the Dearborn automaker on-track to be the first to deliver U.S.-made lithium-iron phosphate batteries for ...
TALON PV is poised to anchor the U.S. solar supply chain by establishing an independent, 9.6 GW domestic cell manufacturing ...
Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.
A roundtable discussion reveals how hybrid distributed models could provide a bridge from centralized cell-therapy ...
As the U.S. solar PV sector scales up domestic cell manufacturing, long-term competitiveness will depend on whether American ...
HEFEI, ANHUI, CHINA, January 19, 2026 /EINPresswire.com/ — The global photovoltaic (PV) industry is entering a phase defined less by headline capacity additions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results